title: The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
abstract: The Epidemiology of Diabetes Interventions and Complications (EDIC) study, an observational follow-up of the Diabetes Control and Complications Trial (DCCT) type 1 diabetes cohort, measured coronary artery calcification (CAC), an index of atherosclerosis, with computed tomography (CT) in 1,205 EDIC patients at approximately 7-9 years after the end of the DCCT. We examined the influence of the 6.5 years of prior conventional versus intensive diabetes treatment during the DCCT, as well as the effects of cardiovascular disease risk factors, on CAC. The prevalences of CAC >0 and >200 Agatston units were 31.0 and 8.5%, respectively. Compared with the conventional treatment group, the intensive group had significantly lower geometric mean CAC scores and a lower prevalence of CAC >0 in the primary retinopathy prevention cohort, but not in the secondary intervention cohort, and a lower prevalence of CAC >200 in the combined cohorts. Waist-to-hip ratio, smoking, hypertension, and hypercholesterolemia, before or at the time of CT, were significantly associated with CAC in univariate and multivariate analyses. CAC was associated with mean HbA(1c) (A1C) levels before enrollment, during the DCCT, and during the EDIC study. Prior intensive diabetes treatment during the DCCT was associated with less atherosclerosis, largely because of reduced levels of A1C during the DCCT.
authors.affiliation: Diabetes Unit, Massachusetts General Hospital, 32 Fruit St., Boston, MA 02114-2698, USA.
authors.forename: Patricia A
authors.initials: PA
authors.lastname: Cleary
authors.forename: Trevor J
authors.initials: TJ
authors.lastname: Orchard
authors.forename: Saul
authors.initials: S
authors.lastname: Genuth
authors.forename: Nathan D
authors.initials: ND
authors.lastname: Wong
authors.forename: Robert
authors.initials: R
authors.lastname: Detrano
authors.forename: Jye-Yu C
authors.initials: JY
authors.lastname: Backlund
authors.forename: Bernard
authors.initials: B
authors.lastname: Zinman
authors.forename: Alan
authors.initials: A
authors.lastname: Jacobson
authors.forename: Wanjie
authors.initials: W
authors.lastname: Sun
authors.forename: John M
authors.initials: JM
authors.lastname: Lachin
authors.forename: David M
authors.initials: DM
authors.lastname: Nathan
mesh_terms: D000328:Adult; D050197:Atherosclerosis / Q000517:prevention & control; D001786:Blood Glucose / Q000378:metabolism*; D002114:Calcinosis / Q000503:physiopathology*; D015331:Cohort Studies; D023921:Coronary Stenosis / Q000453:epidemiology / Q000503:physiopathology*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000453:epidemiology / Q000517:prevention & control*; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D015995:Prevalence
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin